Trimethylamine N-oxide promotes lymphoid differentiation of hematopoietic stem and progenitor cells
Molecular Immunology · 2026-11 · 199 · 129-142
DOI: 10.1016/j.molimm.2026.09.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2026-11. Verfasst von Min Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospita…. Hauptthemen laut MEDLINE: Methylamines, Hematopoietic Stem Cells, Cell Differentiation, Lymphocytes. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hubei University of Medicine, Hubei Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Persistent lymphopenia represents a clinically relevant adverse effect associated with radiotherapy, surgery and infection and is linked to unfavorable clinical outcomes. Trimethylamine N-oxide (TMAO), a gut microbiota-derived metabolite generated from dietary choline and L-carnitine, has emerged as a potential regulator of host physiology; however, its role in lymphoid differentiation remains unclear. METHODS: c-Kit⁺ hematopoietic stem and progenitor cells (HSPCs) were isolated from mouse bone marrow using immunomagnetic beads and subjected to an in vitro lymphoid differentiation assay. Normal and irradiated C57BL/6 mice were treated with L-carnitine by gavage, a high-choline diet, or TMAO-containing drinking water. Serum TMAO concentrations were measured by LC-MS/MS. Lymphoid populations in the bone marrow, spleen, and peripheral blood were analyzed by flow cytometry and routine blood tests, and the underlying mechanism was examined using pharmacological inhibition, qPCR, and Western blotting. RESULTS: TMAO promoted the lymphoid differentiation of mouse c-Kit⁺ HSPCs in vitro. Mice treated with L-carnitine by gavage, a high-choline diet, or TMAO-containing drinking water had increased serum TMAO levels. These TMAO-elevating interventions increased the lymphoid cell proportions in the bone marrow, spleen, and peripheral blood and increased the HSPC population. This lymphoid-promoting effect was further evident in irradiated mice, in which TMAO accelerated lymphoid recovery. Mechanistically, TMAO activated its receptor, PERK, leading to increased PERK phosphorylation and subsequent upregulation of HOXA9/Pim-1 signaling, whereas inhibition of PERK or HOXA9 attenuated the lymphoid-promoting effect of TMAO. CONCLUSIONS: Our findings reveal a previously unrecognized role of TMAO in promoting HSPC lymphoid differentiation through activation of the PERK-HOXA9/Pim-1 signaling axis, providing new insights into potential strategies for managing lymphopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, China.
- Department of Hematology, Taihe Hospital, Shiyan, 442000, China.
- Hubei Clinical Research Center for Reproductive Medicine, Shiyan, Hubei, 442000, China; Shiyan Key Laboratory of Reproduction and Genetics (Renmin Hospital, Hubei University of Medicine), China.
- MOE Engineering Center of Hematological Disease, Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. Electronic address: zhweng@suda.edu.cn.
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, China. Electronic add…
Förderung
- Hubei University of Medicine
- Hubei Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M., Mei, H., Bai, X., Peng, W., Jiang, H., Zhang, L., Sun, Z., Weng, Z., & Yuan, Y. (2026). Trimethylamine N-oxide promotes lymphoid differentiation of hematopoietic stem and progenitor cells. Molecular Immunology, 199, 129-142. https://doi.org/10.1016/j.molimm.2026.09.010
Vancouver
Zhang M, Mei H, Bai X, Peng W, Jiang H, Zhang L, et al. Trimethylamine N-oxide promotes lymphoid differentiation of hematopoietic stem and progenitor cells. Molecular Immunology. 2026;199:129-142. doi:10.1016/j.molimm.2026.09.010
BibTeX
@article{Zhang2026,
author = {Zhang, Min and Mei, Hanyi and Bai, Xinyu and Peng, Wensi and Jiang, Hua and Zhang, Lulu and Sun, Zhifeng and Weng, Zhen and Yuan, Yahong},
title = {Trimethylamine N-oxide promotes lymphoid differentiation of hematopoietic stem and progenitor cells},
journal = {Molecular Immunology},
year = {2026},
volume = {199},
pages = {129--142},
doi = {10.1016/j.molimm.2026.09.010}
}
EUVIMED